Ivermectin treatment of a traveler who returned from Peru with cutaneous gnathostomiasis.
We describe a 21-year-old patient who experienced a relapse of cutaneous gnathostomiasis after receiving initial treatment with albendazole and who had a successful outcome after receiving a short course of ivermectin for the relapse. This is the first reported case of gnathostomiasis acquired by a human in Peru.
Chappuis
F
F
Travel and Migration Medicine Unit, Department of Community Medicine, Geneva University Hospital, Geneva, Switzerland.
Farinelli
T
T
Loutan
L
L
D000328:Adult; D000818:Animals; D000909:Antibodies, Helminth / Q000097:blood; D000969:Antinematodal Agents / Q000627:therapeutic use*; D000977:Antiparasitic Agents; D005260:Female; D006039:Gnathostoma / Q000276:immunology*; D006801:Humans; D007559:Ivermectin / Q000627:therapeutic use*; D010568:Peru; D012008:Recurrence; D012876:Skin Diseases, Parasitic / Q000175:diagnosis / Q000469:parasitology; D017205:Spirurida Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000469:parasitology; D014195:Travel
D000909:Antibodies, Helminth; D000969:Antinematodal Agents; D000977:Antiparasitic Agents; D007559:Ivermectin